Abstract
Objectives
The aim of this study was to assess the quality of tuberculosis (TB) care for the whole course and assess factors that affect completing treatment.
Design
This is an observational retrospective study using chart abstraction for the whole course of TB care conducted at two underserved provinces in China.
Setting
The study was conducted from June 2021 to July 2021. All medical records (outpatient and inpatient) for the whole course (6–8 months) of patients with TB newly registered from July 2020 to December 2020 were reviewed and abstracted using predetermined checklists.
Participants
A total of 268 outpatient medical records and 126 inpatient records were included.
Primary and secondary outcome measures
The primary outcome included diagnostic quality, treatment quality and management quality. The secondary outcome was completing treatment.
Results
For diagnostic quality, 94.2% of the diagnosis were based on adequate evidence. For treatment quality, 240 (91.6%) outpatients and 100 (85.5%) inpatients took the standard chemotherapy regimens. 234 (87.3%) patients completed treatment. 85.1% of the inpatients prescribed with second-line drugs were inappropriate. For management quality, 128 (47.9%) patients received midterm assessments, but only 47 (19.7%) received sufficient services for the whole course. Patients with TB symptoms were 1.8 times more likely to complete treatment (p=0.011).
Conclusion
Patients with TB received high-quality diagnosis and treatment services, but low-quality whole-course management. Integration of medical and public health services should be strengthened to improve whole-course quality.
Funder
the Center for Project Supervision and Management, National Health Commission, China
Reference31 articles.
1. World Health Organization . Global Tuberculosis Report 2021. Geneva: World Health Organization, 2021.
2. Changes in incidence and Epidemiological characteristics of pulmonary tuberculosis in Mainland China, 2005-2016;Jiang;JAMA Netw Open,2021
3. Ending tuberculosis in China: health system challenges;Long;Lancet Public Health,2021
4. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data;Wang;The Lancet,2014
5. The analysis of national tuberculosis reported incidence and mortality, 2015-2019;Wang;Chin J Antituberc,2021